Altered fractionated radiotherapy in the management of head and neck carcinomas: advantages and limitations

Curr Opin Oncol. 2004 May;16(3):215-9. doi: 10.1097/00001622-200405000-00004.

Abstract

Purpose of review: This article provides an overview of randomized studies of altered fractionated radiotherapy (RT) in Head and Neck squamous cell carcinoma.

Recent findings: Both hyperfractionated RT and accelerated RT may improve tumor control probability as compared to conventional RT, along with increased but manageable toxicity and a modest improvement in survival.

Summary: Altered RT is a tool that can improve the results obtained with conventional RT in Head and squamous cell carcinoma.

Publication types

  • Review

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Carcinoma, Squamous Cell / mortality
  • Carcinoma, Squamous Cell / therapy*
  • Combined Modality Therapy
  • Disease Management
  • Head and Neck Neoplasms / mortality
  • Head and Neck Neoplasms / therapy*
  • Humans
  • Radiotherapy Dosage
  • Radiotherapy* / adverse effects
  • Randomized Controlled Trials as Topic
  • Risk Assessment
  • Survival Rate